are at increased risk of miscarriage following either spontan-1 To whom correspondence should be addressed eous or assisted conception (Stanger and Yovich, 1985; Howles The prevalence of polycystic ovaries (PCO) was established et al., 1987; Homburg et al., 1988; Regan et al., 1990). amongst 2199 consecutive women (median age 33 years;
1 To whom correspondence should be addressed eous or assisted conception (Stanger and Yovich, 1985 ; Howles The prevalence of polycystic ovaries (PCO) was established et al., 1987; Homburg et al., 1988; Regan et al., 1990) . amongst 2199 consecutive women (median age 33 years;
However, a recent prospective randomized placebo controlled range 19-46) with a history of recurrent miscarriage study reported that pre-pregnancy pituitary suppression of high (median 3; 3-14). A diagnosis of PCO was made if the endogenous LH does not improve the live birth rate of women ovarian volume was enlarged (>9 ml), there were ≥10 cysts with recurrent miscarriage and PCO who hypersecrete LH of 2-8 mm in diameter in one plane and there was increased (Clifford et al., 1996) . density of the stroma. In a cohort study, the prospective
We therefore addressed the question of whether PCO pregnancy outcome of 486 of the women scanned who were morphology itself was predictive of adverse pregnancy antiphospholipid antibody negative and who received no outcome amongst ovulatory women with a history of recurrent pharmacological treatment during their next pregnancy miscarriage conceiving spontaneously. Subsidiary aims were was studied. The prevalence of PCO was 40.7% (895/2199).
to establish (i) the prevalence of PCO amongst women with The livebirth rate was similar amongst women with PCO recurrent miscarriage and (ii) the biochemical profile of women (60.9%; 142/233) compared to that amongst women with with recurrent miscarriage and PCO. normal ovarian morphology (58.5%; 148/253; not significant). Neither an elevated serum luteinizing hormone conMaterials and methods centration (>10 IU/l) nor an elevated serum testosterone concentration (>3 nmol/l) was associated with an increased
Subjects miscarriage rate. Polycystic ovarian morphology is not
Ovarian morphology was determined in 2199 consecutive women predictive of pregnancy loss amongst ovulatory women (median age 33 years; range 19-46) with a history of recurrent miscarriage (median 3; 3-14) seen in our specialist miscarriage with recurrent miscarriage conceiving spontaneously. The clinic between 1991 and 1999. We have previously reported on the search for a specific endocrine abnormality that can divide prevalence of PCO morphology amongst the first 500 of these women women with PCO into those with a good and those with (Clifford et al., 1994) . The prospective pregnancy outcome of Introduction graphers on an Ultramark 9 (Advanced Technology Laboratories, Bothel, Seattle, USA) using either a 3.5 MHz abdominal or a 5 MHz Recurrent miscarriage, the loss of three or more consecutive vaginal probe in the early to mid-follicular phase of the menstrual pregnancies, affects 1% of couples trying to conceive. Since cycle. A diagnosis of PCO was made if the ovarian volume was this is significantly higher than that expected by chance alone enlarged (Ͼ9 ml), and there were ജ10 cysts of 2-8 mm in diameter (0.34%), a proportion of couples is likely to have a persistent in one plane and there was increased density of the stroma, which underlying abnormality to account for their repeated pregnancy was subjectively quantified (Adams et al., 1986) . These ultrasound losses. Polycystic ovaries (PCO) are the most commonly criteria have been widely used in European studies to define polycystic identified ultrasound abnormality amongst women with recurovarian morphology (reviewed by Kyei-Mensah et al., 1996) . rent miscarriage (Sagle et al., 1988; Clifford et al., 1994) .
Women with PCO form a heterogeneous group. At one end was measured with a heterogeneous sandwich magnetic separation assay and testosterone with a competitive magnetic separation assay on Figure 1 . Flow diagram of the pregnancies amongst the study the Technicon Immuno 1 Immunoanalyser System (Bayer Corporation, population (n ϭ 2199). PAPS ϭ primary antiphospholipid Tarrytown, New York, USA). The coefficient of variation for the LH syndrome (treated with aspirin and heparin). assay was Ͻ3% and for the testosterone assay 8%. Table II . Demographic details and previous obstetric history of women in All women were screened for aPL on at least two occasions Ͼ6 the pregnancy study. There was no significant difference between the groups weeks apart prior to pregnancy. Lupus anticoagulant (LA) was detected using the dilute Russell's viper venom time (dRVVT) together
Antiphospholipid assays

Normal ovaries
Polycystic ovaries with a platelet neutralization procedure. Patient samples with a
dRVVT ratio (test/control) of ജ1.1 were re-tested with a platelet neutralization procedure. A decrease of ജ10% in the ratio was were considered to be positive (Khamashta and Hughes, 1993) .
trimester miscarriage
Women with persistently positive tests for either LA or aCL were diagnosed as having the primary antiphospholipid syndrome and were treated with aspirin and heparin during pregnancy.
ovarian morphology (Figure 1 ). Amongst women who did not
Management during pregnancy
report a pregnancy, the prevalence of PCO (40.3%; 405/1004) was similar to that of the population prevalence of PCO in
None of the 486 women received pharmacological treatment during their pregnancy, but all were encouraged to attend a dedicated early this study (40.7%). There was no significant difference in pregnancy clinic at which supportive care was offered and serial first either the age nor the number of previous miscarriages between trimester ultrasound scans were performed.
the two groups of women (Table II) . All women had persistently negative tests for aPL and no woman received pharmacological Statistical analysis treatment during pregnancy, except for folic acid as prophylaxis
Normally distributed continuous variables were analysed using the against neural tube defects.
Student's t-test; otherwise the Mann-Whitney U-test was used.
The overall live birth rate was similar amongst women with Discrete variables were analysed using the χ 2 test.
PCO (60.9%; 142/233) compared to that amongst women with normal ovaries (58.5%; 148/253; not significant). There was Results no significant difference in either the mean gestation at delivery or the mean birthweight between women with successful The prevalence of polycystic ovarian morphology amongst women with recurrent miscarriage was 40.7% (895/2199).
pregnancies who had PCO and those who had normal ovarian morphology (Table III) . The majority of miscarriages amongst There were no cases of unilateral PCO. Although the mean follicular phase LH and testosterone concentrations were both groups of women occurred in the first trimester of pregnancy (Table III) . There was no significant difference in significantly higher amongst women with PCO compared to those with normal ovaries, the mean levels of these hormones the future live birth rate between women with PCO and those with normal ovarian morphology irrespective of the number remained within the normal range (Table I ). There was no significant difference in the body mass index [weight (kg/ of previous miscarriages (Figure 2 ). The live birth rate was apparently higher amongst women height (m) 2 ] between the two patient groups (Table I) .
The prospective pregnancy outcome of 233 women with with an elevated LH concentration (Ͼ10 IU/l) compared to that amongst women with a lower LH concentration [38/53 PCO (median age 32 years; range 19-44) and a history of recurrent miscarriage (median 3; 3-14) was compared to that (72%) versus 252/433 (58%); not significant (P ϭ 0.06)]. This difference, however, failed to reach significance. Women with of 253 women (median age 33 years; 19-45) with a history of recurrent miscarriage (median 3; 3-13) who had normal an elevated testosterone concentration (Ͼ3 nmol/l) had a with normal concentrations. We were unable to confirm previ- conception (Howles et al., 1987; Homburg et al., 1988;  (weeks) Hamilton-Fairley et al., 1991) . These apparently deleterious , 1993b; Homburg et al., 1993) . More recent studies have not confirmed these original reports and have questioned the relationship between an elevated LH concentration and recurrent miscarriage. There was no significant difference in the future pregnancy outcome of women with an elevated serum LH concentration compared to those with a normal LH concentration (Tulppala et al., 1993) . A similar result was reported later (Liddell et al., 1997) . Both these studies included only women with three or more consecutive pregnancy losses.
Measurement of LH remains a controversial area. Earlier studies assayed LH concentrations using a classical radioimmunoassay, whilst more recent studies have used immunometric methods. Even when the same reference standard is used, radioimmunoassays in general give higher LH readings than immunometric methods (Balen et al., 1993a) . More recently, a genetic variant of LH (vLH) has been discovered (Tapanainen et al., 1999) . The biological activity of vLH is greater than that of wild-type LH in vitro, but its half-life in similar live birth rate (69.2%) compared to those with a lower the circulation is shorter and the overall effect on in-vivo testosterone concentration (66%; not significant). The live birth bioactivity is unclear. The presence of variant vLH is not rate was also similar amongst women with a cycle length of associated with any clear effect on endocrine variables such Ͼ35 days compared to those with a shorter cycle [10/13 (77%) as endometrial maturation or mid-luteal phase oestradiol and versus 280/473 (59%; not significant)].
progesterone concentrations and does not affect miscarriage rates (Tulppala et al., 1998) . As LH is secreted in a pulsatile Discussion manner we have previously addressed the possibility that tonic hypersecretion of LH, assayed in early morning urine samples Our own unit has reported that the prevalence of PCO amongst an unselected cohort of 257 women is 23% (Polson et al., collected throughout the menstrual cycle, was predictive of miscarriage. In a prospective randomized placebo-controlled 1988). This is in broad agreement with prevalence data subsequently published by others (Farquhar et al., 1994;  study we reported that suppression of high endogenous LH secretion with a GnRH analogue did not improve the live birth Koivunen et al., 1999) . Compared with our historic cohort, the prevalence of PCO (40.7%) is significantly higher amongst rate (Clifford et al., 1996) . Apart from hypersecretion of LH, hyperandrogenemia is a women with recurrent miscarriage compared to that in the general population. In a much smaller study we have previously feature of the polycystic ovarian syndrome. We found that in women with recurrent miscarriage, although the mean reported the prevalence of PCO amongst women with recurrent miscarriage to be 56% (Clifford et al., 1994) . This difference testosterone concentration was significantly higher amongst those with PCO compared to those with normal ovaries, it may be accounted for by the current much larger study being a more accurate reflection of the true population prevalence was still within the normal range (Ͻ3 nmol/l). Women with an elevated testosterone concentration had a similar prospective of PCO amongst women with recurrent miscarriage. However, amongst ovulatory women with a history of recurrent miscarlive birth rate compared to those with a normal testosterone concentration. Other investigators have reported a similar riage conceiving spontaneously, PCO morphology per se does not predict an increased risk of future pregnancy loss.
relationship between free testosterone concentrations and future pregnancy outcome (Liddell et al., 1997) . However, this is not Furthermore, there was no significant difference in the prospective livebirth rate between those women with either an elevated a universal finding. Increased concentrations of androgens have been reported amongst women with recurrent miscarriage serum follicular phase LH concentration (Ͼ10 IU/l) or an elevated testosterone level (Ͼ3 nmol/l) compared to those and that these increased concentrations are (i) associated with This large data set has allowed us to examine the relationship Stanger, J.D. and Yovich, J.L. (1985) Reduced in-vitro fertilization of human between polycystic ovarian morphology and recurrent miscaroocytes from patients with raised basal luteinizing hormone levels during riage. Although PCO are found significantly more often the follicular phase. Br. J. Obstet. Gynaecol., 92, 385-393. Tapanainen, J.S., Koivunen, R., Fauser, B.C. et al. (1999) A new contributing amongst women with recurrent miscarriage than in the normal factor to polycystic ovary syndrome: the genetic variant of luteinizing population, ovarian morphology itself is not a risk factor hormone. J. Clin. Endocrinol. Metab., 84, 1711 -1715 for future pregnancy loss amongst women with recurrent Tulppala, M., Stenman, U.H., Cacciatore, B. and Ylikorkala, O. (1993) miscarriage conceiving spontaneously. The search for a specific Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br. J. Obstet. Gynaecol., 100, endocrine abnormality that can divide women with PCO into 348-352. those with a good and those with a poorer prognosis for a Tulppala, M., Huhtaniemi, I. and Ylikorkala, O. (1998) Received on October 7, 1999; accepted on November 25, 1999 
